We came across a bullish thesis on Intuitive Surgical, Inc. on Uncle Stock Notes’s Substack. In this article, we will ...
LUNR stock (NASDAQ: LUNR) is down due to overall tech sell-off, no specific news driving decline. Mixed technical indicators.
With nine new procedures cleared for the da Vinci 5 robot, Intuitive’s strategy includes working with a limited number of U.S ...
Intuitive Machines stock is still a "Buy" amid a 72% gain and reaching out price target. Here's what investors need to know.
Intuitive Surgical receives FDA clearance for the da Vinci 5 robot to be used in cardiac procedures, reports 18% procedure ...
Medical Device Network on MSN
Intuitive receives FDA clearance for non-force feedback instruments in cardiac procedures
Intuitive CEO Dave Rosa highlighted that the clearance related to “several cardiac” procedures for non-force instruments used ...
This robotic surgical systems pioneer is dealing with a few issues, but its opportunities remain promising.
Intuitive Surgical's 2025 earnings were strong, and the future remains bright, with valuation as the only big concern for ...
Intuitive Surgical has received FDA clearance for cardiac procedures using the da Vinci 5 surgical robot, according to a Jan. 26 report from Mass Device. The new cardiac clearances cover mitral valve ...
The acquisition aligns with the Intuitive Machines vision, strengthening the Company's position as a vertically integrated next generation space prime that is able to build, connect, and operate ...
Fourth quarter 2025 GAAP net income attributable to Intuitive was $795 million, or $2.21 per diluted share, compared with $686 million, or $1.88 per diluted share, in the fourth quarter of 2024.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results